Theoretical study on pegylation reaction mechanisms of IFN-α-2a, IFN-α-2b and IFN-β-1a

Mohammad Taqavian, Daryoush Abedi, Fatemeh Zigheimat, Leila Zeidabadinejad

Abstract


Ab initio and DFT calculations have been carried out to study the reaction mechanism between IFN-α-2a, IFN-α-2b and IFN-β-1a and polyethylene glycol (PEG) group. The calculations show that the mechanisms are concerted in agreement with the results of experimental works. However, although it appears that there is one single transition state, the characteristics of its structure reveal a very synchronous reaction mechanism. The reactions are clearly exothermic and as well have feasible activation energies. Our computational study shows that the lowest transition state energies are related to Lys 134, His 34 and Met 1 of IFN-α-2a, IFN-α-2b and IFN-β-1a, respectively.

Keywords


IFN-α-2a; IFN-α-2b; IFN-β-1a; pegylation; transition state; DFT

Full Text:

PDF (1,386 kB)

References


G. Sen, P. Lengyel, J. Biol. Chem. 267 (1992) 5017

S. K. Tyring, Am. J. Obstet. Gynecol. 172 (1995) 1350

M. Peters, Hepatology. 23 (1996) 909

R. G. Tsanev, I. Ivanov, Immune interferon: properties and clinical applications, CRC Press, Boca Raton, FL, 2001

B. Perussia, M. Kobayashi, M. E. Rossi, I. Anegon, G. Trinchieri, J. Immunol. 138 (1987) 765

K. Fantes, In Vitro Monogr. 3 (1974) 48

J. Parkin, B. Cohen, Lancet. 357 (2001) 1777

V. Gaberc-Porekar, I. Zore, B. Podobnik, V. Menart, Curr. Opin. Drug. Disc. Dev. 11 (2008) 242

T. Thomas, G. Foster, Int. J. Nanomedicine. 2 (2007) 19

J. Frey, R. Peck, W. Bollag, Cancer. Lett. 57 (1991) 223

S. Maher, A. Romero-Weaver, A. Scarzello, A.M. Gamero, Curr. Med. Chem. 14 (2007) 1279

P. Bailon, W. Berthold, J. Pharm. Sci. 1 (1998) 352

D. Baker, Rev Gastroenterol Disord. 3 (2002) 93

Y.-S. Wang, S. Youngster, J. Bausch, R. Zhang, C. McNemar, D. F. Wyss, Biochem. J. 39 (2000) 10634

H. Yano, S. Ogasawara, S. Momosaki, J. Akiba, S. Kojiro, S. Fukahori, H. Ishizaki, K. Kuratomi, Y. Basaki, S. Oie, Liver. Int. 26 (2006) 964

M. Talpaz, H. Kantarjian, R. Kurzrock, J. M. Trujillo, J. U. Gutterman, Ann. Intern. Med. 114 (1991) 532

H. M. Kantarjian, S. O'Brien, T. L. Smith, M. B. Rios, J. Cortes, M. Beran, C. Koller, F. J. Giles, M. Andreeff, S. Kornblau, J. Clin. Oncol. 17 (1999) 284

L. D. Jacobs, D. L. Cookfair, R. A. Rudick, R. M. Herndon, J. R. Richert, A. M. Salazar, J. S. Fischer, D. E. Goodkin, C. V. Granger, J. H. Simon, Ann. Neurol. 39 (1996) 285

R. A. Rudick, N. Simonian, J. Alam, M. Campion, J. Scaramucci, W. Jones, M. Coats, D. Goodkin, B. Weinstock-Guttman, R. Herndon, Neurology 50 (1998) 1266

Y. Mitsui, T. Senda, T. Shimazu, S. Matsuda, J. Utsumi, Pharmacol. Ther. 58 (1993) 93

G. Uzé, G. Lutfalla, K. E. Mogensen, J. Interferon. Cytokin. Res. 15 (1995) 3

R. Camble, N. Petter, P. Trueman, C. Newton, F. Carr, R. Hockney, V. Moore, A. Greene, D. Holland, M. Edge, Biochem. Biophys. Res. Commun. 134 (1986) 1404

J. M. Harris, R. B. Chess, Nat. Rev. Drug Discov. 2 (2003) 214

S. P. Monkarsh, Y. Ma, A. Aglione, P. Bailon, D. Ciolek, B. Debarbieri, M. C. Graves, K. Hollfelder, H. Michel, A. Palleroni, Anal. Chem. 247 (1997) 434

K. R. Reddy, M. W. Modi, S. Pedder, Adv. Drug Deliv. Rev. 54 (2002) 571

P. Bailon, A. Palleroni, C. A. Schaffer, C. L. Spence, W.-J. Fung, J.E. Porter, G. K. Ehrlich, W. Pan, Z.-X. Xu, M. W. Modi, Bioconjugate Chem. 12 (2001) 195

C. Dhalluin, A. Ross, W. Huber, P. Gerber, D. Brugger, B. Gsell, H. Senn, Bioconjugate Chem. 16 (2005) 518

Y.-S. Wang, S. Youngster, M. Grace, J. Bausch, R. Bordens, D. F. Wyss, Adv. Drug Deliv. Rev. 54 (2002) 547

D. P. Baker, E. Y. Lin, K. Lin, M. Pellegrini, R. C. Petter, L. L. Chen, R. M. Arduini, M. Brickelmaier, D. Wen, D. M. Hess, Bioconjugate Chem. 17 (2006) 179

M. Frisch, G. Trucks, H. B. Schlegel, G. Scuseria, M. Robb, J. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. Petersson, Gaussian 09, revision A. 02, Gaussian, Inc., Wallingford, CT, 2009

S. Huzinaga, Comput. Phys. Rep. 2 (1985) 281

M. M. van Beers, W. Jiskoot, H. Schellekens, J. Interf. Cytokin. Res. 30 (2010) 767.




DOI: http://dx.doi.org/10.2298/JSC161126044T

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 J. Serb. Chem. Soc.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

IMPACT FACTOR 0.822 (131 of 166 journals)
5 Year Impact Factor 1.015 (118 of 166 journals)